CFDE Data Portal | Search BNIP3P37

	Label	Description
	BNIP3P37 Gene (Entity type)	ENSG00000270479 - BCL2 interacting protein 3 pseudogene 37
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101788 GSE101791 MYC inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115643 CTB 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210150 crizotinib cardiac muscle cell 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172219 adenosine 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 7 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	KCNN1 IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

BNIP3P37

ENSG00000270479 - BCL2 interacting protein 3 pseudogene 37

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE77108 saha 6 v 9 human up

A Gene Set from LINCS

GSE101788 GSE101791 MYC inhibition 0 v 1 human up

A Gene Set from LINCS

GSE233679 nicotinamide 6 v 8 human dn

A Gene Set from LINCS

GSE115643 CTB 0 v 1 human up

A Gene Set from LINCS

GSE210150 crizotinib cardiac muscle cell 0 v 1 human up

A Gene Set from LINCS

GSE172219 adenosine 3 v 5 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 7 v 4 human up

A Gene Set from LINCS

KCNN1 IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.